| CAS No. | 172733-08-3 |
|---|---|
| MDL No. | N/A |
| MF | C22H22N2O5 |
| MW | 394.40 |
| InChI Key | VJYDOJXJUCJUHL-UHFFFAOYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 99.97% ; | $231 | In Stock | |
| 5 mg | 99.97% ; | $560 | In Stock | |
| 10 mg | 99.97% ; | $892 | In Stock | |
| 25 mg | 99.97% ; | $1308 | In Stock | |
| 50 mg | 99.97% ; | $1823 | In Stock | |
| 100 mg | 99.97% ; | $2457 | In Stock | |
| 200 mg | 99.97% ; | $3299 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Varespladib methyl is a methyl ester formed by the condensation of varespladib's carboxy group with methanol. It serves as a prodrug, anti-inflammatory agent, antidote, and inhibitor of EC 3.1.1.4 (phospholipase A2). It is used in the treatment of snakebite envenomations caused by PLA2 toxins. It is a methyl ester, aromatic ether, member of benzenes, indoles, and primary carboxamides, and functionally related to varespladib.
| CAS No. | 172733-08-3 |
|---|---|
| Product Name | Varespladib Methyl |
